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Abstract
Background: Curcumin is a principal compound of turmeric, commonly used to treat tumors and other diseases.
However, its anti-cancer activity in human acute monocytic leukemia THP-1 cells is not clear. This study aimed to
study the anti-cancer effect and action of curcumin on THP-1 cells.
Methods: THP-1 parental cells and PMA-treated THP-1 cells, were used as in vitro models to evaluate the anti-
cancer effect and mechanism of curcumin. Apoptosis and its mechanism were evaluated by WST-1, flow cytometry
and Western blotting. MAPK inhibitors were used to further confirm the molecular mechanism of curcumin-
induced THP-1 cell apoptosis.
Results: Curcumin induced cell apoptosis of THP-1 cells as shown by cell viability, cell cycle analysis and caspase
activity. Curcumin significantly increased the phosphorylation of ERK, JNK and their downstream molecules (c-Jun
and Jun B). Inhibitor of JNK and ERK reduced the pro-apoptotic effect of curcumin on THP-1 cells as evidenced by
caspase activity and the activation of ERK/JNK/Jun cascades. On the contrary, the pro-apoptotic effect of curcumin
was abolished in the differentiated THP-1 cells mediated by PMA.
Conclusions: This study demonstrates that curcumin can induce the THP-1 cell apoptosis through the activation of
JNK/ERK/AP1 pathways. Besides, our data suggest its novel use as an anti-tumor agent in acute monocytic
leukemia.
Background
Acute myeloid leukemia (AML) is a hematopoietic can-
cer characterized by a disorder in differentiation of hema-
topoiesis; this disease results in the growth of a clonal
population of neoplastic cells. Malignant hematopoietic
cells lead to loss of normal hematopoietic functions,
which results in death within weeks to months [1]. AML
is the most common type of leukemia in adults. It has
the lowest survival rate of all leukemia [2]. A better
understanding of the molecular biology of AML will be
helpful when developing new therapeutic strategies that
specifically target molecular abnormalities.
Mitogen-activated protein kinases (MAPKs) such as
ERK, JNK and p38 mediate the signaling transduction
involved in cell proliferation, differentiation, transforma-
tion survival and death [3]. Several publications showed
the involvement of MAPKs in the apoptosis of HL-60
cells isolated from the patients with human promyelocy-
tic leukemia, one type of acute myeloid leukemia. For
instance, the activation of p38/ERK, JNK/ERK and p38/
JNK by anti-cancer compounds, trifolin acetate [4],
fucoidan [5] and 3,6-dihydroxyflavone [6], respectively,
were observed during HL60 cell death. Accordingly, AP-
1 transcription factor is associated with JNK mediated
HL-60 cell apoptosis [7-10]. These data support the
notion that the MAPKs and the downstream transcrip-
tion factor AP-1 are the major mediators of HL-60
apoptosis.
Medicinal plants, used in complementary and alterna-
tive medicine, are an extraordinary source of chemopre-
ventive and therapeutic agents for various human
tumors [11,12]. Turmeric has traditionally been used as
a component to treat a variety of disorders in the Indian
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curcumin, the principal curcuminoid of turmeric, inhi-
bits proliferation and induce apoptosis in various types
of solid tumor and leukemia cell lines [13,14]. Curcumin
has been reported to possess inhibitory effects on MDR1
and WT1 gene expression in AML patient leukemic
cells [15,16]. Several studies have revealed that curcumin
induces HL-60 cell line (a promyelocytic leukemia type
of AML) apoptosis through several pathways, including
the ornithine decarboxylase-dependent pathway [17], ER
stress [18] and an inhibition of telomerase activity [19].
However, little is known about the effects of curcumin
on other types of AML.
In the present study, we investigated the effect and
mode of action of curcumin on monocytic leukemia
THP-1 cells. We first examined the effect of different
concentrations of curcumin on THP-1 cell apoptosis.
Next, interference of the inhibitor of ERK and JNK and
PMA-treated THP-1 cells were used to study the likely
mechanism of curcumin-mediated apoptosis.
Methods
Cell and reagents
The THP-1 cell line, derived from human acute mono-
cytic leukemia, was purchased from American Type
Culture Collection (TIB-202). Cells were cultured in
RPMI-1640 (Gibco) supplemented with 10% FBS
(Gibco), 10 mM HEPES (GeneMark), 1% L-glutamine
(Gibco), 1% non-essential amino acids (Gibco). Curcu-
min, dimethyl sulfoxide (DMSO), SP600125 (ERK inhi-
bitor), U0126 (JNK inhibitor) and phorbol-12-myristate-
13-acetate (PMA) were purchased from Sigma. Antibo-
dies against caspase-3, cleaved caspase-8, Caspase-9,
FoxO4, phospho-FoxO4 (Thr28), FoxO3a, FoxO1, phos-
pho-FoxO1 (Ser256), phospho-FoxO3a (Ser253), p85,
phospho-p85 (Tyr458), p110a,P D K 1 ,P h o s p h o - P D K 1 ,
JunB, c-Jun, phospho-c-Jun Ser63, AKT1, AKT2, AKT3,
phospho-AKT (Ser473), phospho-AKT (Ser308), ATF2,
phospho-ATF2 Thr71, phospho-JNK (Thr183/Tyr185),
phospho-ERK (Thr202/Tyr2040), ERK, JNK, p38, phos-
pho-p38 (Thr180/Tyr182), caspase-8 and histone H3
were purchased from Cell signaling laboratory and anti-
bodies against PARP-1, caspase-3 and GAPDH were
from Epitomics Inc. b-actin antibody and phospho-JunB
(Ser259) were purchased from Sigma and Santa Cruz
Biotechnology, respectively.
Flow cytometry
THP-1 cells, which had been treated with curcumin (30
μM, 40 μMa n d5 0μM), were harvested and fixed with
70% ethanol at 4°C overnight. After PBS washing, the cells
were incubated with RNase A for 5 min. After incubation
with propidium iodide (200 μg/mL), the cells underwent
flow cytometry (Beckman, FC-500). For double staining,
THP-1 cells were first treated with PhipPhiLux-G1D2/cas-
pase-3 substrate (OncoImmuno, Inc) at 37°C for 45 min.
After washing, the cells were stained with propidium
iodide and analyzed using flow cytometry.
Protein extraction and immunoblotting
THP-1 cells were lyzed with RIPA lysis buffer (Sigma).
Total cell lysates were extracted as described previously
(Chen et al., 2009). The lysates were separated using
polyacrylamide gel electrophoresis. After transfer, the
membrane was blotted with antibody and developed
with an enhanced chemiluminescent kit.
Caspase activity assay
THP-1 cells were treated with DMSO and curcumin (50
μM) in the presence of U0126 (20 μM) and SP600125
(30 μM) for 10 hours. The cells were subsequently incu-
bated with Caspase-Glo
® 3/7 reagent kit (Promega) and
caspases-3/7 activity was detected and analyzed using a
GloMax
®-Multi Detection System (Promega) according
to the manufacturer’s instructions.
WST-1 assays
THP-1 cells and PMA-treated tHP-1 cells were seeded at
the density of 50 000 cells/cm
2 in 96-well plates. The
cells were incubated with DMSO and 50 μMc u r c u m i n
for 18 hr. After washing, the cells were incubated with
WST-1 reagent at 37°C for 1 hr in accordance to the
manufacturer’s instructions (Roche). The quantity of for-
mazan dye was determined with a photometer at 450 nm.
Statistics
Data from three independent experiments are presented
as mean ± standard deviation (SD). Student’s t-test was
used for statistical analysis between control and treat-
ment groups. P less than 0.05 is considered statistically
significant.
Results
Curcumin induces THP-1 cell apoptosis
To investigate the anti-cancer effect of curcumin on
THP-1 cells, a cell line of human monocytic leukemia,
THP-1 cells at exponentially growing stage were incu-
bated with different concentrations (30, 40 and 50 μM)
of curcumin for 24 hours. DMSO did not affect cell
cycle in THP-1 cells (Figure 1A). The subG1 fractions
of curcumin-treated THP-1 cells were significantly
increased in a concentration-dependent manner (Figure
1A). In contrast, the G2/M fractions were decreased
(Figure 1A). However, the G0/G1 and S fractions
s e e m e dn o tt oc h a n g e( F i g u r e1 A ) .T h ed a t as u g g e s t
that curcumin can induce cell death of THP-1 cells.
Furthermore, we studied the time course of cell death of
THP-1 cells treated with curcumin. We found that
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Page 2 of 8DMSO did not induce THP-1 cell death (Figure 1B). In
contrast, curcumin at 50 mM significantly enhanced the
subG1 fractions and this enhancement peaked at 24
hours (Figure 1B). Besides, we analyzed the apoptosis of
curcumin-treated THP-1 cells using caspase-3/7 activity
and propidium iodide staining. The data revealed that
curcumin induced THP-1 cell death via apoptotic path-
way (Figure 2A). To further study if curcumin activated
intrinsic and extrinsic pathways during apoptosis, we
examined the cleavage of caspase-8, a caspase in the
extrinsic pathway, caspase-9, a caspase in the intrinsic
pathway, caspase-3 and PARP-1, substrates of caspases.
The results showed the activation of caspases by curcu-
min started at 3 hours post-treatment, followed by the
degradation of PARP-1 (Figure 2B). Taken, together, the
data suggest that curcumin concentration-dependently
induces THP-1 cell apoptosis through both the extrinsic
and intrinsic apoptotic pathways.
Apoptosis of THP-1 cells by curcumin is not mediated by
PI3K/AKT pathway
PI3K/AKT/FOXO pathway is well known for regulation
of cell survival and apoptosis (Burgering and Medema,
2003). Therefore, we examined the involvement of
PI3K/AKT/FOXO pathway in the curcumin-mediated
apoptosis in THP-1 cells. Figure 3A showed that curcu-
min treatment did not alter the phosphorylation level of
PI3K, AKTs and FOXOs in THP-1 cells.
Apoptosis of THP-1 cells by curcumin is mediated by the
activation of JNK/ERK/Jun pathways
We turned to examine the involvement of MAPK path-
ways in the curcumin-mediated apoptosis in THP-1
cells. We found that curcumin increased the phosphory-
lation level of JNK and ERK to a greater extent than
p38 in THP-1 cells (Figure 3B). Accordingly, curcumin
augmented the phosphorylation of c-Jun and JunB, the
downstream transcription factors of JNK and ERK, in
THP-1 cells (Figure 3B).
To further verify the role of the JNK and ERK path-
ways in the curcumin-induced THP-1 cell apoptosis, we
tested if the inhibitors of JNK (SP600125) and ERK
(U0126) could reverse curcumin-mediated apoptosis in
THP-1 cells as evidenced by the activity of caspases-3/7.
As expected, both inhibitors reduced curcumin-induced
caspase-3/7 activity in THP-1 cells in a concentration-
dependent manner (Figure 4A and 4B). However, no
synergistic or additive effect was observed when these
two inhibitors were combined (Figure 4C), implying that
JNK and ERK might be redundant in this system. Con-
sistently, Inhibition of ERK reduced the phosphorylation
of ERK, JunB and, to a lesser extent, c-Jun (Figure 4D).
In sharp contrast, Inhibition of JNK reduced the phos-
phorylation of JNK and c-Jun (Figure 4D). Besides, the
percentage of sub-G1 population in THP-1 cells treated
with vehicle and curcumin with/without the inhibitors
of ERK, JNK or both was assessed using DNA content
assays. Curcumin significantly increased the percentage
of the sub-G1 population (i.e., apoptotic cells) of THP-1
cells. This sub-G1 population induced by curcumin was
further reduced by the inhibitor of ERK and JNK. A
more pronounced reductioni ns u b - G 1p o p u l a t i o nw a s
observed in THP-1 cells treated with combinational
inhibitors (Figure 4E). The data on the reduction of cur-
cumin-mediated THP-1 cella p o p t o s i sb yt h eM A P K
inhibitors using DNA content assays is consistent with
those obtained from capase-3/7 assays (Figure 4A to
4C). Overall, the data suggest that curcumin modulates
apoptosis in THP-1 cells via the activation of JNK/ERK/
Jun pathways. ERK and JNK pathways may be parallel
and redundant in the curcumin-induced THP-1 cell
apoptosis.
PMA treatment reduces curcumin-induced THP-1 cell
apoptosis by inhibiting ERK/JNK/Jun pathways
PMA is known to induce differentiation of THP-1
monocytic cells into macrophage-like cells (Auwerx et
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Figure 1 Effect of curcumin on THP-1 cell apoptosis. (A) THP-1
cells treated with vehicle (-) and curcumin (CUR, 30, 40 and 50 μM)
for 24 hours underwent propidium iodide (PI) staining and flow
cytometry. The percentage of the cells in different cell cycle phases
was decided and replotted into histogram. Data from three
independent experiments are presented as mean ± SD. P (*) < 0.05.
(B) THP-1 cells treated with vehicle (-) and 50 μM curcumin (CUR)
for 3, 12 and 24 hours were subjected to the same procedure as
(A). Data from three independent experiments are presented as
mean ± SD. P (*) < 0.05.
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Page 3 of 8al., 1992). Next, we compared the effect of curcumin on
PMA-treated THP-1 cells, differentiated/mature mono-
cytic cells, and THP-1 cells using WST-1 assays. We
found that cell viability of PMA-treated THP-1 cells and
THP-1 cells after curcumin treatment was 25 ± 0.5%
and 96 ± 3.7%, respectively. The data suggest that PMA
treatment dramatically reversed curcumin-induced
THP1 cell death.
Next, we examined the effect of curcumin on the
ERK/JNK/Jun, caspase-3 and AKT pathways in PMA-
treated THP-1 cells. We found that curcumin decreased
the phosphorylation of ERK, JNK, c-Jun and JunB and
the degradation of caspase-3 in PMA-treated THP-1
cells (Figure 5A) as opposed to THP-1 cells (Figure 3B).
In contrast, curcumin increased the phosphorylation of
AKT (Figure 5A). The data showed that PMA treatment
reversed the apoptotic effect of curcumin on THP-1
cells via the inactivation of ERK/JNK/Jun pathways and
activation of AKT pathway. Overall, our data support
the notion that curcumin induces the apoptosis of
human monocytic leukemia THP-1 cells via the activa-
tion of JNK/ERK/Jun pathways (Figure 5B).
Discussion
In this work, we showed that curcumin induced the
apoptosis of THP-1 cells, a human acute monocytic
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Figure 2 Effect of curcumin on the activation of caspases in THP-1 cells. (A) THP-1 cells were treated with vehicle (DMSO) and 50 μM
curcumin (CUR) for 3, 12 and 24 hours. The cells were stained with propidium iodide (PI) staining and fluorescent caspase-3/7 substrate. PI
intensity and caspase-3/7 activity were analyzed by flow cytometry. The data are representative of 3 experiments. (B) THP-1 cells were treated
with 50 μM curcumin (CUR) for 0, 3, 12, 24 and 36 hours. Total lysates of the cells were subjected to SDS-PAGE electrophoresis and blotted with
the antibodies against caspase-8, caspase-9, caspase-3 and PARP1. The data are representative of 3 experiments.
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Page 4 of 8leukemia cell line. This cell death was associated with
the MAKP and AP1 pathways. The study proves the
concept that curcumin is therapeutically effective against
human acute monocytic leukemia, one key type of acute
myeloid leukemia.
PI3K, AKT and MAPKs are involved in regulation of
life and death [3,20]. Our results showed that curcumin
increased apoptosis via the activation of ERK and JNK
but not PI3K and AKT (Figure 3). Several anti-cancer
compounds such as trifolin acetate [4], fucoidan [5] and
3,6-dihydroxyflavone [6] activated ERK, JNK and/or p38,
in human acute myeloid leukemia HL60 cells. The acti-
vation of MAPKs was related to apoptosis of HL60 cells
[7-10]. Hence, our and other data suggest that MAPKs
regulates the matter of life and death in leukemia cells.
Jun family proteins have dual roles in neoplasia and
tumor suppression and their roles need to be considered
in a context-dependent manner [21-23]. For example,
JunB was shown to repress cell proliferation when c-Jun:
JunB heterodimers were formed [24,25]. JunB was also
reported to have tumor suppressor function in chronic
myeloid leukemia [26,27] and B cells [28]. More
recently, JunB was shown to inhibit autophagy and
induce apoptosis [29,30]. Consistently, AP-1 was shown
to be implicated in HL-60 cell apoptosis mediated by
JNK [7-10]. In this study, our results showed that c-Jun
and JunB are involved in the curcumin-induced apopto-
sis in THP1 cells (Figures 3B, 4D and 5), suggesting the
tumor suppressor role of c-Jun and JunB in THP-1 cells.
Collectively, this study showed that curcumin induces
THP-1 apoptosis via the activation of ERK/JNK path-
ways and its downstream mediators, c-Jun and JunB.
The data are in good agreement with the publications
indicating that MAPK/AP1 pathways regulated cell
death in acute myeloid leukemia HL60 cells. Moreover,
our and other data support the notion that the MAPKs
Akt
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Figure 3 Effect of curcumin on PI3K/AKT and MAPK pathways in THP-1 cells. THP-1 cells were treated with 50 μM curcumin (CUR) for 0, 3,
6 and 12 hours. Total lysates of the cells were subjected to SDS-PAGE electrophoresis and blotted with the antibodies against the molecules of
PI3K (A) and MAPK (B) pathways. The data are representative of 3 experiments.
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Page 5 of 8Figure 4 JNK and ERK inhibitors reduce the apoptotic effect of curcumin in THP-1 cells. (A) THP-1 cells, which were pre-treated with 50
μM curcumin (CUR) for 2 hours, were incubated with 15 and 30 μM JNK inhibitor (SP600125) for an additional 10 hours. The caspase-3/7 activity
of THP-1 cells (1.2 × 10
4) was determined. Data from 3 independent experiments are presented as mean ± SD. P (*) < 0.05. (B) The same
procedure as (A) except that the curcumin-treated cells were incubated with 10 and 20 μM ERK inhibitor (U0126). Data from three independent
experiments are presented as mean ± SD. P (*) < 0.05. (C) The same procedure as (A) except that the curcumin-treated cells were incubated
with 20 μM ERK inhibitor (CUR + U0126), 30 μM JNK inhibitor (CUR + SP600125) and both (CUR + SP + U). Data from three independent
experiments are presented as mean ± SD. P (*) < 0.05. (D) THP-1 cells, which were treated with 50 μM curcumin (CUR) for 2 hours, were
incubated with 20 μM ERK inhibitor (U0126) and 30 μM JNK inhibitor (SP600125) for additional 10 hours. Total lysates of the cells were separated
and blotted with the indicated antibodies. The data are representative of 3 experiments. (E) THP-1 cells, which were treated with 50 μM
curcumin (CUR) for 2 hours, were incubated with 20 μM ERK inhibitor (U0126),30 μM JNK inhibitor (SP600125) or both for additional 10 hours.
The cells were stained with propidine iodine (PI), followed by flow cytometry analysis.
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Page 6 of 8and the downstream molecule, AP-1, are the major
mediators that regulate cell death of AML tumors.
Leukemic cells are aberrant immature blood cells. Dif-
ferentiation of leukemic cells is thought as an anti-leu-
kemia approach. PMA, a PKC activator, is known to
promote the differentiation of immature THP-1 mono-
cytic cells to mature THP-1 macrophages. Interestingly,
the apoptotic effect of curcumin was abolished in PMA-
treated THP-1 cells. Surprisingly, phosphorylation of
ERK, JNK and Jun by curcumin decreased in PMA-trea-
ted THP-1 cells (Figure 5A). Phosphorylation of AKT
seemed to increase (Figure 5A). The data suggest that
apoptotic effect of curcumin is more effective against
immature leukemic cells than mature cells. Put together,
curcumin induces human monocytic leukemic THP-1
cell apoptosis via the activation of MAPK/AP1
pathways.
Conclusions
This work shows the pro-apoptotic effect and mechan-
ism of curcumin in THP-1 cells. Its apoptotic action
involves the activation of JNK/ERK/AP1 pathways.
Besides, our data imply the novel use of curcumin as
anti-leukemia agent.
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